4.3 Article

Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly

期刊

NEUROREPORT
卷 24, 期 2, 页码 58-62

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0b013e32835c5254

关键词

Alzheimer's disease; BMI; brain structure; leptin; MRI; obesity

资金

  1. NIH [U01 AG024904, R01 EB008281, R01 AG020098, P30 AG010129, K01 AG030514]
  2. Alzheimer's Disease Neuroimaging Initiative (ADNI)
  3. National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
  4. Abbott
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. Amorfix Life Sciences Ltd
  8. AstraZeneca
  9. Bayer HealthCare
  10. BioClinica Inc.
  11. Biogen Idec Inc.
  12. Bristol-Myers Squibb Company
  13. Eisai Inc.
  14. Elan Pharmaceuticals Inc
  15. Eli Lilly and Company
  16. F. Hoffmann-La Roche Ltd
  17. Genentech Inc.
  18. GE Healthcare
  19. Innogenetics N.V.
  20. IXICO Ltd.
  21. Janssen Alzheimer Immunotherapy Research & Development, LLC
  22. Johnson & Johnson Pharmaceutical Research & Development, LLC
  23. Medpace Inc.
  24. Merck Co. Inc.
  25. Meso Scale Diagnostics, LLC
  26. Novartis Pharmaceuticals Corporation
  27. Pfizer Inc.
  28. Servier
  29. Synarc Inc.
  30. Takeda Pharmaceutical Company
  31. Canadian Institutes of Health Research

向作者/读者索取更多资源

Leptin, a hormone produced by body fat tissue, acts on hypothalamic receptors in the brain to regulate appetite and energy expenditure, and on neurons in the arcuate nucleus to signal that an individual has had enough to eat. Leptin enters the central nervous system at levels that depend on an individual's body fat. Obese people, on average, show greater brain atrophy in old age, so it is valuable to know whether brain atrophy relates to leptin levels, which can be targeted by interventions. We therefore determined how plasma leptin levels, and BMI, relate to brain structure, and whether leptin levels might account for BMI's effect on the brain. We measured regional brain volumes using tensor-based morphometry, in MRI scans of 517 elderly individuals with plasma leptin measured (mean: 13.3+/-0.6 ng/ml; mean age: 75.2+/-7.3 years; 321 men/196 women). We related plasma leptin levels to brain volumes at every location in the brain after adjusting for age, sex, and diagnosis and, later, also BMI. Plasma leptin levels were significantly higher (a) in women than men, and (b) in obese versus overweight, normal or underweight individuals. People with higher leptin levels showed deficits in frontal, parietal, temporal and occipital lobes, brainstem, and the cerebellum, irrespective of age, sex, or diagnosis. These associations persisted after controlling for BMI. Greater brain atrophy may occur in people with central leptin insufficiency, a marker of obesity. Therapeutic manipulation of leptin may be a promising direction for slowing brain decline. NeuroReport 24:58-62 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. NeuroReport 2013, 24:58-62

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据